De Groot AC: New contact allergens: 2008 to 2015. Dermatitis 2015;26:199.
Aytan J: Use of biologics in SLE: A review of the evidence from a clinical perspective. Rheumatology 2016;55:775
Cantini F et al: Tailored first-line biologic therapy in patient with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis. Semin Arthritis Rheum 2016;45:519.
Marzano AV et al: Immune-mediated inflammatory reactions and tumors as skin side effects of inflammatory bowel disease therapy. Autoimmunity 2014;47:146.
Tiligada E et al: The expanding role of immunopharmacology: IUPHAR review 16. Br J Pharmacol 2015;172:4217.
Sriaroon P, Ballow M: Immunoglobulin replacement therapy for primary immunodeficiency. Immunol Allergy Clin North Am 2015;35:713.
Capron A et al: Intra-cellular immunosuppressive drug monitoring: A step forward towards better therapeutic efficacy after organ transplantation? Pharmacol Res 2016;111:610.
Choi WE, Reddy P: Current and emerging strategies for the prevention of graftversus-host disease. Nat Rev Clin Oncol 2014;11:536.
Lee JH et al: A comprehensive review of the treatment of atopic eczema. Allergy Asthma Immunol Res 2016;8:181.
Sharma P, Scott DG: Optimizing methotrexate treatment in rheumatoid arthritis: Prior to biologics. Drugs 2015;75:1953.
Waldner M et al: New perspectives on mTOR inhibitors (rapamycin, rapalogs, and TORKinibs) in transplantation. Br J Clin Pharmacol 2016;82:1158.
Costa AG, Bilezikian JP: How long to treat with Denosumab. Curr Osteoporos Rep 2015;13:415.
Cummings SR: Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 2009;361:756.
Spain L et al: Management of toxicities of immune checkpoint inhibitors. Cancer Treat Rev 2013;44:51.
Wolf M et al: Peripheral administration of antithymocyte globulins: A review of current literature. Transplant Rev (Orlando) 2013;27:17.
Akdis M et al: Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β and TNF-α: Receptors, functions and roles in diseases. J Allergy Clin Immunol 2016;138:984.
Khan DA: Hypersensitivity and immunologic reactions to biologics: Opportunities for the allergist. Ann Allergy Asthma Immunol 2016;117:115.
Macy E: Practical management of patients with a history of immediate hypersensitivity to common non-beta-lactam drugs. Curr Allergy Asthma Rep 2016;16:4.
Wickner PG, Hong D: Immediate drug hypersensitivity Curr Allergy Asthma Rep 2016;16:49.